18 results
8-K
EX-1.1
BHVN
Biohaven Ltd.
2 Oct 23
Other Events
9:41pm
to the Company by the Manager expressly for use therein.
(d)Disclosure Package. At the Execution Time, at each Applicable Time, at each Settlement Date … and each Time of Delivery, the Disclosure Package does not contain any untrue statement of a material fact or omit to state any material fact necessary
8-K
EX-99.1
BHVN
Biohaven Ltd.
27 Sep 23
Regulation FD Disclosure
6:58am
of adipose tissue Advanced Development Program Large preclinical and clinical safety package licensed from BMS Existing database includes pediatric
8-K
EX-99.1
BHVN
Biohaven Ltd.
28 Jul 23
Biohaven Provides Preliminary EEG Data Update for Kv7 Platform, Regulatory Update on Troriluzole and Other Corporate Updates
4:35pm
. The approximately 6,000 patients in North America at least deserved a thorough review of the data package submitted.
Approximately 200 patients have … the available data. We believe the NDA package is compelling and shows that treatment with troriluzole leads to clinically meaningful treatment benefits
424B4
pzl2mt4f6 gqzn5
24 Oct 22
Prospectus supplement with pricing info
9:38am
S-1/A
gxv y69hdntyl0x9q
20 Oct 22
IPO registration (amended)
10:00am
S-1
87xzl 1nh2
18 Oct 22
IPO registration
4:03pm
DRS
jnoa4v
11 Oct 22
Draft registration statement
12:00am
10-12B/A
EX-99.1
gica0l9 nv2byqdf
20 Sep 22
Registration of securities (amended)
6:30am
10-12B/A
EX-99.1
tk9q4zh3ly1shg
14 Sep 22
Registration of securities (amended)
5:25pm
10-12B/A
EX-99.1
ruh9 611vot3be15t
7 Sep 22
Registration of securities (amended)
7:26am
10-12B/A
EX-99.1
n7o6vzrmskf19 2nfyyd
24 Aug 22
Registration of securities (amended)
5:03pm
10-12B
EX-10.2
ebu10hawkeo88
10 Aug 22
Registration of securities
5:07pm
10-12B
EX-99.1
8mkllhdq noa877
10 Aug 22
Registration of securities
5:07pm
10-12B
EX-10.1
nwkleb
10 Aug 22
Registration of securities
5:07pm
DRS
EX-99.1
b8gpbyne1n 804wopt
1 Jul 22
Draft registration statement
12:00am
- Prev
- 1
- Next